Searched for
PARENTERAL DRUG ASSOCIATION
FDA approval puts Wockhardt’s Zaynich in $9 billion antibiotics marketWockhardt's new antibiotic, Zaynich, has received US FDA approval. This drug uses a novel mechanism to fight drug-resistant bacteria. It ta...- Long-term Investing: Ecosystem with an edge called India; 12 large- mid- and small-cap stocks with upside potential of up to 34%Tactical investing should not be confused with long-term investing. In a world where geopolitical risk, commodity shocks, and uncertainty a...
- Eris Lifesciences acquires Biocon Biologics domestic branded formulation business for Rs 1,242 croreAs part of the deal over 430 employees associated with the business are expected to transition to Eris, ensuring continuity for both employ...
- Nirma to acquire 75% of Glenmark’s API arm for Rs 5,615 crGlenmark Pharma’s stake in the leading active pharmaceutical ingredient (API) platform will drop to 7.84% from 82.84%. The transaction valu...
- ET MSME Awards: Announcing the nominees for India’s most unbiased MSME awardsEconomictimes.com has announced nominees for all 26 awards of the third edition of the ET MSME Awards 2022. The winners will be announced a...
- US-based Amneal Pharmaceuticals buys India's injectable maker Punishka Healthcare for Rs 700 croresAmneal Pharmaceuticals on Tuesday said it has acquired Ahmedabad-based injectable drug maker Puniska Healthcare Pvt. Ltd for a total value ...
- Questions on data integrity undermines framework of trust: Richard Johnson, PDAIn all of the activities of PDA worldwide, we work to identify best practices and target continuous improvement in pharmaceutical processes.
- Claris Lifesciences gets USFDA drug approvalClaris Lifesciences Ltd, a parenteral drug company has received drug approval from US drug authorities for hypertension and angina treatmen...
- GMP norms for drug cos put off by 1 yearThe government has deferred compulsory implementation of the new good manufacturing practices (GMP) norms for the drug industry by one year.
Load More
